SYNAPTIC PLASTICITY IN THE RAT STRIATUM FOLLOWING CHRONIC HALOPERIDOL TREATMENT

被引:69
作者
KERNS, JM
SIERENS, DK
KAO, LC
KLAWANS, HL
CARVEY, PM
机构
[1] RUSH PRESBYTERIAN ST LUKES MED CTR, DEPT NEUROL SCI, 2242 W HARRISON ST AF0048, CHICAGO, IL 60612 USA
[2] RUSH PRESBYTERIAN ST LUKES MED CTR, DEPT ANAT, CHICAGO, IL 60612 USA
[3] RUSH PRESBYTERIAN ST LUKES MED CTR, DEPT PHARMACOL, CHICAGO, IL 60612 USA
关键词
DOPAMINE; HALOPERIDOL; SYNAPTIC PLASTICITY; TROPHIC FACTORS; STRIATUM; PERFORATED SYNAPSES;
D O I
10.1097/00002826-199212000-00006
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Administration of the dopamine (DA) antagonist haloperidol leads to the development of behavioral hypersensitivity as well as enhanced neuronal growth when striatal extracts from these animals are incubated with mesencephalic cultures. For determining if alterations in neuronal growth also occur in vivo, the ultrastructure of the neuropil in the dorsolateral quadrant of the striatum from rats treated (24 days) with haloperidol (1.25 mg/kg) was examined by electron microscopy. Haloperidol-treated rats developed statistically significant behavioral hypersensitivity relative to vehicle-treated controls (p < 0.01). Evaluation of the neuropil revealed that haloperidol treatment enhanced, relative to vehicle-treated controls, the overall number of synaptic boutons by 9% (p < 0.01). The number of perforated synaptic profiles as well as the number of double synapses was increased by 20 and 50%, respectively, although this increase was not statistically significant. The number of myelinated axons remained unchanged, while the number of dendritic spines was increased by 21% (p < 0.05). These data suggest that chronic haloperidol treatment enhanced the growth and possible sprouting of presynaptic neurons and also induced postsynaptic plastic changes. These ultrastructural changes may contribute in part to hypersensitivity behaviors.
引用
收藏
页码:488 / 500
页数:13
相关论文
共 51 条
[11]  
CARVEY PM, 1990, PROG BRAIN RES, V82, P693
[12]   DOPAMINERGIC ALTERATIONS IN COTREATMENTS ATTENUATING HALOPERIDOL-INDUCED HYPERSENSITIVITY [J].
CARVEY, PM ;
LI, CK ;
ZHANG, TJ ;
AMDUR, RL ;
DONG, HL ;
SINGH, R ;
KLAWANS, HL .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1990, 35 (02) :291-300
[13]   STRIATAL HOMOGENATES FROM ANIMALS CHRONICALLY TREATED WITH HALOPERIDOL STIMULATE DOPAMINE AND GABA UPTAKE IN CULTURES OF ROSTRAL MESENCEPHALIC TEGMENTUM [J].
CARVEY, PM ;
PTAK, LR ;
KAO, LC ;
KLAWANS, HL .
CLINICAL NEUROPHARMACOLOGY, 1989, 12 (05) :425-434
[14]   EFFECTS OF DOPAMINE ANTAGONISTS AND APOMORPHINE ON REGIONAL ENERGY-METABOLISM IN RAT CNS [J].
CARVEY, PM ;
BRAUN, AR ;
KAO, LC ;
KLAWANS, HL .
CLINICAL NEUROPHARMACOLOGY, 1987, 10 (03) :247-260
[15]   CLOZAPINE FAILS TO PREVENT THE DEVELOPMENT OF HALOPERIDOL-INDUCED BEHAVIORAL HYPERSENSITIVITY IN A COTREATMENT PARADIGM [J].
CARVEY, PM ;
NATH, ST ;
KAO, LC ;
ZHANG, TJ ;
LIN, DH ;
SINGH, R ;
AMDUR, RL ;
KLAWANS, HL .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 184 (01) :43-53
[16]   LEVODOPA REDUCES THE GROWTH-PROMOTING EFFECTS OF STRIATAL EXTRACTS ON ROSTRAL MESENCEPHALIC TEGMENTUM CULTURES [J].
CARVEY, PM ;
PTAK, LR ;
LO, ES ;
LIN, DH ;
BUHRFIEND, CM ;
GOETZ, CG ;
KLAWANS, HL .
EXPERIMENTAL NEUROLOGY, 1991, 114 (01) :28-34
[17]  
CHRISTENSEN AV, 1979, PSYCHOPHARMACOLOGY, V62, P111, DOI 10.1007/BF00427122
[18]   IDENTIFICATION OF SYNAPTIC TERMINALS OF THALAMIC OR CORTICAL ORIGIN IN CONTACT WITH DISTINCT MEDIUM-SIZE SPINY NEURONS IN THE RAT NEOSTRIATUM [J].
DUBE, L ;
SMITH, AD ;
BOLAM, JP .
JOURNAL OF COMPARATIVE NEUROLOGY, 1988, 267 (04) :455-471
[19]  
FIBIGER HC, 1984, TRENDS NEUROSCI, V7, P462
[20]  
FOG SR, 1977, PSYCHOPHARMACOLOGY B, V50, P305